tradingkey.logo

Senestech Inc

SNES
1.870USD
+0.090+5.06%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
9.77MValor de mercado
PerdaP/L TTM

Mais detalhes de Senestech Inc Empresa

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

Informações de Senestech Inc

Código da empresaSNES
Nome da EmpresaSenestech Inc
Data de listagemDec 08, 2016
CEOFruendt (Joel L)
Número de funcionários23
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 08
Endereço777 W. Pinnacle Peak Road
CidadePHOENIX
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal85027
Telefone19287794143
Sitehttps://senestech.com/
Código da empresaSNES
Data de listagemDec 08, 2016
CEOFruendt (Joel L)

Executivos da empresa Senestech Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Matthew K. (Matt) Szot, CPA
Mr. Matthew K. (Matt) Szot, CPA
Independent Director
Independent Director
1.00
-1.00%
Mr. Thomas C. (Tom) Chesterman
Mr. Thomas C. (Tom) Chesterman
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
--
--
Dr. Jamie Bechtel, J.D., Ph.D.
Dr. Jamie Bechtel, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Phil N. Grandinetti, III
Mr. Phil N. Grandinetti, III
Independent Director
Independent Director
--
--
Mr. Jake S. Leach
Mr. Jake S. Leach
Independent Director
Independent Director
--
--
Mr. Joel L. Fruendt
Mr. Joel L. Fruendt
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Joshua M. Moss
Mr. Joshua M. Moss
Independent Director
Independent Director
--
--
Ms. Lynn Y. Graham
Ms. Lynn Y. Graham
Independent Director
Independent Director
--
--
Mr. Michael Edell
Mr. Michael Edell
Chief Operating Officer
Chief Operating Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Matthew K. (Matt) Szot, CPA
Mr. Matthew K. (Matt) Szot, CPA
Independent Director
Independent Director
1.00
-1.00%
Mr. Thomas C. (Tom) Chesterman
Mr. Thomas C. (Tom) Chesterman
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
--
--
Dr. Jamie Bechtel, J.D., Ph.D.
Dr. Jamie Bechtel, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Phil N. Grandinetti, III
Mr. Phil N. Grandinetti, III
Independent Director
Independent Director
--
--
Mr. Jake S. Leach
Mr. Jake S. Leach
Independent Director
Independent Director
--
--
Mr. Joel L. Fruendt
Mr. Joel L. Fruendt
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: qua, 5 de mar
Moeda: USDAtualizado em: qua, 5 de mar
FY2024Q2
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
459.00K
0.00%
International
0.00
0.00%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: dom, 1 de fev
Atualizado em: dom, 1 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Glenbrook Capital Management
11.53%
PFS Cap MGT Co
4.21%
Renaissance Technologies LLC
2.02%
Sabby Management, LLC
1.36%
The Vanguard Group, Inc.
1.31%
Outro
79.56%
Investidores
Investidores
Proporção
Glenbrook Capital Management
11.53%
PFS Cap MGT Co
4.21%
Renaissance Technologies LLC
2.02%
Sabby Management, LLC
1.36%
The Vanguard Group, Inc.
1.31%
Outro
79.56%
Tipos de investidores
Investidores
Proporção
Hedge Fund
15.19%
Corporation
4.21%
Investment Advisor/Hedge Fund
2.87%
Investment Advisor
2.63%
Research Firm
0.20%
Outro
74.90%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
34
578.80K
11.18%
+387.29K
2025Q3
27
159.90K
3.23%
+38.59K
2025Q2
29
110.88K
6.13%
-56.71K
2025Q1
31
108.03K
6.02%
-48.91K
2024Q4
32
178.31K
17.25%
+80.51K
2024Q3
38
76.44K
15.87%
+51.77K
2024Q2
37
16.40K
4.22%
-8.22K
2024Q1
40
19.23K
5.47%
+9.13K
2023Q4
37
6.33K
7.03%
+618.00
2023Q3
35
1.33K
4.01%
+245.00
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Glenbrook Capital Management
90.00K
1.72%
+90.00K
--
Sep 30, 2025
PFS Cap MGT Co
220.00K
4.21%
+129.49K
+143.08%
Jun 30, 2025
Renaissance Technologies LLC
105.64K
2.02%
+105.64K
--
Sep 30, 2025
Sabby Management, LLC
71.28K
1.36%
+71.28K
--
Sep 30, 2025
The Vanguard Group, Inc.
61.36K
1.17%
+47.86K
+354.63%
Sep 30, 2025
Corsair Capital Management, L.P.
55.15K
1.06%
+5.10K
+10.19%
Sep 30, 2025
Geode Capital Management, L.L.C.
35.80K
0.69%
+24.15K
+207.36%
Sep 30, 2025
DRW Securities, LLC
30.29K
0.58%
+30.29K
--
Sep 30, 2025
Millennium Management LLC
28.71K
0.55%
+28.71K
--
Sep 30, 2025
Essex Investment Management Company, LLC
26.18K
0.5%
+26.18K
--
Sep 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Nov 15, 2023
Merger
12→1
Nov 15, 2023
Merger
12→1
Data
Data ex-dividendo
Tipo
Proporção
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Jul 23, 2024
Merger
10→1
Nov 15, 2023
Merger
12→1
Nov 15, 2023
Merger
12→1
Nov 15, 2023
Merger
12→1
Nov 15, 2023
Merger
12→1
Nov 15, 2022
Merger
20→1
Nov 15, 2022
Merger
20→1
Ver Mais
KeyAI